Skip to Content

Veeva Systems Inc Class A VEEV Stock Quote

| Rating as of

NYSE:VEEV

Morningstar‘s Stock Analysis VEEV

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

We Are Lowering Wide-Moat Veeva's FVE to $257 Due To Revised Outlook; Shares Still Attractive

Keonhee Kim Equity Analyst

Analyst Note

| Keonhee Kim |

After taking a fresh look at our key valuation assumptions, we have lowered our fair value estimate roughly 7% to $257 per share due to our revised outlook of segment growth.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics VEEV

Company Profile VEEV

Business Description

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a sales force, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Contact
4280 Hacienda Drive
Pleasanton, CA, 94588
T +1 925 452-6500
Industry Health Information Services
Most Recent Earnings Jul 31, 2022
Fiscal Year End Jan 31, 2023
Employees 5,482

Related News VEEV